Murphy, SM, Lilleker, JB, Helliwell, P et al. (1 more author) (2016) The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome. Rheumatology, 55 (12). pp. 2277-2278. ISSN 1462-0324
Metadata
Authors/Creators: |
|
---|---|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 11 May 2018 11:04 |
Last Modified: | 11 May 2018 11:04 |
Status: | Published |
Publisher: | Oxford University Press |
Identification Number: | https://doi.org/10.1093/rheumatology/kew296 |
Related URLs: |
Download not available
A full text copy of this item is not currently available from White Rose Research Online